| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |